# Cyclacel Pharmaceuticals, Inc. (BGMS) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | — |
| 2024 | $43,000 |
| 2023 | $420,000 |
| 2022 | — |
| 2021 | — |
| 2020 | — |
| 2018 | $150,000 |
| 2017 | — |
| 2016 | $843,000 |
| 2015 | $2M |
| 2014 | $2M |
| 2013 | $1M |
| 2012 | $69,000 |
| 2011 | $699,000 |
| 2010 | $112,000 |
| 2009 | $911,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $743,000 |
| 2025-09-30 | $81,000 |
| 2024-09-30 | $10,000 |
| 2024-06-30 | $4,000 |
| 2024-03-31 | $29,000 |
| 2023-09-30 | $16,000 |
| 2023-06-30 | $373,000 |
| 2023-03-31 | — |
| 2022-09-30 | — |
| 2022-06-30 | — |
| 2022-03-31 | — |
| 2021-09-30 | — |
| 2021-06-30 | — |
| 2021-03-31 | — |
| 2020-09-30 | — |
| 2020-06-30 | — |
| 2019-06-30 | — |
| 2019-03-31 | — |
| 2018-09-30 | — |
| 2018-06-30 | — |
| 2018-03-31 | — |
| 2017-09-30 | — |
| 2017-06-30 | — |
| 2017-03-31 | — |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BGMS/revenue)